CAS 1907685-81-7 appears in our catalog under these names: Foscarbidopa, Foscarbidopa, 95.91%, (αS)-α-Hydrazinyl-3-hydroxy-α-methyl-4-(phosphonooxy)benzenepropanoic acid, 95%, (αS)-α-Hydrazinyl-3-hydroxy-α-methyl-4-(phosphonooxy)benzenepropanoic acid. Offered by: GLPBio, MedChemExpress, Chemat. Available pack sizes: 1mg, 5 mg, 25 mg, 10 mg, 100 mg, 50 mg, 250mg, 1g.
Foscarbidopa is an L-tyrosine derivative that is carbidopa in which the hydroxy group at position 4' is replaced by a phosphonooxy group. It is a water-soluble prodrug of carbidopa which is used for the treatment of Parkinson's disease. It has a role as an antiparkinson drug and a prodrug. It is an O-phosphoamino acid, a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. It is functionally related to a carbidopa (anhydrous).
Source: ChEBI
| Molecular formula | C10H15N2O7P |
|---|---|
| Molecular weight | 306.21 g/mol |
| IUPAC name | (2S)-2-hydrazinyl-3-(3-hydroxy-4-phosphonooxyphenyl)-2-methylpropanoic acid |
| InChIKey | PQUZXFMHVSMUNG-JTQLQIEISA-N |
| SMILES | C[C@](CC1=CC(=C(C=C1)OP(=O)(O)O)O)(C(=O)O)NN |
Computed by PubChem (NCBI)